⌘K
Loading ticker…
Gyre Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Gyre Therapeutics, Inc. Common Stock (GYRE) has a 3-month relative strength percentile of 25 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.4%, relative volume 9.43×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
25 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
GYRE is in a stage 4 downtrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -6.3% / -15.6%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
GYRE is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $5M notional. Top 3 carry $9M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $5M |
| IWMiShares Russell 2000 ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $664K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GYRE Jan avg: -14.04% median: -4.88% win: 33% σ: 34.16% n: 3 2023-11-01 → 2026-05-29 | GYRE Feb avg: 16.43% median: 1.85% win: 100% σ: 26.17% n: 3 2023-11-01 → 2026-05-29 | GYRE Mar avg: -17.50% median: -15.41% win: 0% σ: 15.01% n: 3 2023-11-01 → 2026-05-29 | GYRE Apr avg: 8.62% median: 10.19% win: 67% σ: 18.64% n: 3 2023-11-01 → 2026-05-29 | GYRE May avg: -19.10% median: -23.05% win: 0% σ: 10.62% n: 3 2023-11-01 → 2026-05-29 | GYRE Jun avg: -6.97% median: -6.97% win: 50% σ: 16.96% n: 2 2023-11-01 → 2026-05-29 (current) | GYRE Jul avg: 8.61% median: 8.61% win: 50% σ: 17.94% n: 2 2023-11-01 → 2026-05-29 | GYRE Aug avg: 2.48% median: 2.48% win: 50% σ: 10.34% n: 2 2023-11-01 → 2026-05-29 | GYRE Sep avg: -6.28% median: -6.28% win: 0% σ: 3.76% n: 2 2023-11-01 → 2026-05-29 | GYRE Oct avg: 8.96% median: 8.96% win: 100% σ: 7.17% n: 2 2023-11-01 → 2026-05-29 | GYRE Nov avg: 78.99% median: 0.00% win: 33% σ: 147.78% n: 3 2023-11-01 → 2026-05-29 | GYRE Dec avg: -0.98% median: -3.28% win: 33% σ: 9.28% n: 3 2023-11-01 → 2026-05-29 |